InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Browse the detailed record of transactions filed by Climaco John M, Chairman & CEO. Director active across 1 companies, notably CNS Pharmaceuticals, Inc.. Aggregated, 3 filings have been logged. The latest transaction was disclosed on 7 March 2022 — Attribution. Regulator: SEC (Form 4). The full history is accessible without signup.
Declarations3 total
€9,04435,000 shares@ €0.25840.23% mcap44.5% of flow
Common Stock
SEC:0001683168-22-001495:0·
€5,6315,000 shares@ €1.1261100.0% of flow
Common Stock
SEC:0001683168-21-005823·
€5,6315,000 shares@ €1.12610.14% mcap27.7% of flow
Common Stock
SEC:0001683168-21-005823:0·
3 of 3 declarations
About Climaco John M
John M. Climaco is the Chief Executive Officer of CNS Pharmaceuticals, Inc. He leads the company with a strategic vision focused on innovation in the pharmaceutical field. His role includes overseeing operations and developing new initiatives to improve patient health. His experience in the pharmaceutical industry is a major asset for the company.
